Alireza Shahedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alireza Shahedi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hamed Delam
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Hossein Kargar Jahromi
Research Center for Non‐Communicable Disease Jahrom University of Medical Sciences Jahrom Iran
1 shared publication - Jaber Zabihirad
Student Research Committee Shiraz University of Medical Sciences Shiraz Iran
1 shared publication - Mahsa Taghipour
School of Nursing and Midwifery Shahrekord University of Medical Sciences Shahr‐e‐Kord Iran
1 shared publication - Mohammad Sadegh Moradi Sarcheshmeh
Bachelor of Surgical Technology, Nurse and Midwifery Faculty Shahed University Tehran Iran
1 shared publication
Latest Publications
- 22 July 2026
- Published by Wiley in Neurourology and Urodynamics
Global Prevalence of Urinary Incontinence in Individuals With Dementia: A Systematic Review and Meta‐Analysis
Background: Urinary incontinence (UI) is a common and debilitating complication in patients with dementia, significantly impacting quality of life, increasing caregiver burden, and accelerating institutionalization. Objective: Despite numerous studies, reported prevalence estimates vary widely, and a precise global pooled prevalence has not been established. Methods: This systematic review and meta‐analysis followed PRISMA guidelines. A comprehensive search of PubMed/MEDLINE, Scopus, and Web of Science was conducted from November to December 2025, without publication year restrictions. Observational studies reporting the point prevalence of UI in dementia patients were included. Two independent reviewers screened studies, extracted data, and assessed methodological quality using the Newcastle‐Ottawa Scale. A random‐effects meta‐analysis (restricted maximum likelihood method) was used to pool prevalence estimates. Heterogeneity was assessed using the I 2 statistic. Subgroup analyses were performed by setting and UI assessment method, and meta‐regression examined associations with Human Development Index (HDI) and temporal trends. Results: Ten studies comprising 286,544 participants were included. The pooled global prevalence of UI in dementia patients was 39.7% (95% CI: 23.9%–58.1%), with substantial heterogeneity (I 2 > 95%). Prevalence ranged from 4% in Taiwan to 88% in Japan. Subgroup analyses revealed significantly higher prevalence in clinic/hospital settings compared to community settings (47.5% vs. 28.7%, p = 0.023), and in studies using single‐question interviews versus medical record extraction (59.2% vs. 23.2%, p = 0.016). Meta‐regression showed a significant positive association with HDI (coefficient: 5.69, p < 0.001). Sensitivity analysis confirmed the robustness of the pooled estimate. Conclusion: Approximately 40% of dementia patients experience UI, with substantial variation by setting and assessment method. Standardized assessment protocols are needed to inform targeted interventions and reduce disease burden.
- 22 July 2026
- Published by Wiley in Neurourology and Urodynamics
Global Prevalence of Urinary Incontinence in Individuals With Dementia: A Systematic Review and Meta‐Analysis
Background: Urinary incontinence (UI) is a common and debilitating complication in patients with dementia, significantly impacting quality of life, increasing caregiver burden, and accelerating institutionalization. Objective: Despite numerous studies, reported prevalence estimates vary widely, and a precise global pooled prevalence has not been established. Methods: This systematic review and meta‐analysis followed PRISMA guidelines. A comprehensive search of PubMed/MEDLINE, Scopus, and Web of Science was conducted from November to December 2025, without publication year restrictions. Observational studies reporting the point prevalence of UI in dementia patients were included. Two independent reviewers screened studies, extracted data, and assessed methodological quality using the Newcastle‐Ottawa Scale. A random‐effects meta‐analysis (restricted maximum likelihood method) was used to pool prevalence estimates. Heterogeneity was assessed using the I 2 statistic. Subgroup analyses were performed by setting and UI assessment method, and meta‐regression examined associations with Human Development Index (HDI) and temporal trends. Results: Ten studies comprising 286,544 participants were included. The pooled global prevalence of UI in dementia patients was 39.7% (95% CI: 23.9%–58.1%), with substantial heterogeneity (I 2 > 95%). Prevalence ranged from 4% in Taiwan to 88% in Japan. Subgroup analyses revealed significantly higher prevalence in clinic/hospital settings compared to community settings (47.5% vs. 28.7%, p = 0.023), and in studies using single‐question interviews versus medical record extraction (59.2% vs. 23.2%, p = 0.016). Meta‐regression showed a significant positive association with HDI (coefficient: 5.69, p < 0.001). Sensitivity analysis confirmed the robustness of the pooled estimate. Conclusion: Approximately 40% of dementia patients experience UI, with substantial variation by setting and assessment method. Standardized assessment protocols are needed to inform targeted interventions and reduce disease burden.